209 related articles for article (PubMed ID: 25186097)
61. Treatment of systemic JIA: When do we need a biologic? Real world data of a single center.
Adiguzel Dundar H; Acari C; Turkucar S; Unsal E
Mod Rheumatol; 2021 May; 31(3):684-690. PubMed ID: 32343644
[TBL] [Abstract][Full Text] [Related]
62. Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease prevention.
Morgan SL; Baggott JE; Lee JY; Alarcón GS
J Rheumatol; 1998 Mar; 25(3):441-6. PubMed ID: 9517760
[TBL] [Abstract][Full Text] [Related]
63. Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis.
Bulatovic M; Heijstek MW; Van Dijkhuizen EH; Wulffraat NM; Pluijm SM; de Jonge R
Ann Rheum Dis; 2012 Sep; 71(9):1484-9. PubMed ID: 22473625
[TBL] [Abstract][Full Text] [Related]
64. Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors.
Mannion ML; Xie F; Curtis JR; Beukelman T
J Rheumatol; 2014 Oct; 41(10):2078-84. PubMed ID: 25086081
[TBL] [Abstract][Full Text] [Related]
65. Treatment Satisfaction With and Adherence to Disease-Modifying Antirheumatic Drugs in Adult Patients With Juvenile Idiopathic Arthritis.
Tollisen A; Flatø B; Selvaag AM; Aasland A; Ingebrigtsen T; Sagen J; Lerdal A
Arthritis Care Res (Hoboken); 2021 Feb; 73(2):221-231. PubMed ID: 31758669
[TBL] [Abstract][Full Text] [Related]
66. Nicotinamide Phosphoribosyltransferase Attenuates Methotrexate Response in Juvenile Idiopathic Arthritis and In Vitro.
Funk RS; Singh R; Pramann L; Gigliotti N; Islam S; Heruth DP; Ye SQ; Chan MA; Leeder JS; Becker ML
Clin Transl Sci; 2016 Jun; 9(3):149-57. PubMed ID: 27166432
[TBL] [Abstract][Full Text] [Related]
67. Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexate.
Moncrieffe H; Bennett MF; Tsoras M; Luyrink LK; Johnson AL; Xu H; Dare J; Becker ML; Prahalad S; Rosenkranz M; O'Neil KM; Nigrovic PA; Griffin TA; Lovell DJ; Grom AA; Medvedovic M; Thompson SD
Rheumatology (Oxford); 2017 Sep; 56(9):1542-1551. PubMed ID: 28582527
[TBL] [Abstract][Full Text] [Related]
68. A longterm prospective real-life experience with leflunomide in juvenile idiopathic arthritis.
Alcântara AC; Leite CA; Leite AC; Sidrim JJ; Silva FS; Rocha FA
J Rheumatol; 2014 Feb; 41(2):338-44. PubMed ID: 24334641
[TBL] [Abstract][Full Text] [Related]
69. Folate Supplementation for Methotrexate Therapy in Patients With Rheumatoid Arthritis: A Systematic Review.
Liu L; Liu S; Wang C; Guan W; Zhang Y; Hu W; Zhang L; He Y; Lu J; Li T; Liu X; Xuan Y; Wang P
J Clin Rheumatol; 2019 Aug; 25(5):197-202. PubMed ID: 29975207
[TBL] [Abstract][Full Text] [Related]
70. Disease activity and damage in juvenile idiopathic arthritis: methotrexate era versus biologic era.
Giancane G; Muratore V; Marzetti V; Quilis N; Benavente BS; Bagnasco F; Alongi A; Civino A; Quartulli L; Consolaro A; Ravelli A
Arthritis Res Ther; 2019 Jul; 21(1):168. PubMed ID: 31287015
[TBL] [Abstract][Full Text] [Related]
71. ; LIVER LESION IN CHILDREN WITH JUVENILE IDIOPATHIC ARTHRITIS WITH DIFFERENT DURATION OF METHOTREXATE TREATMENT.
Panko N; Tsiura O; Shevchenko N; Zimnytska T
Georgian Med News; 2020; (304-305):95-99. PubMed ID: 32965257
[TBL] [Abstract][Full Text] [Related]
72. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.
Giannini EH; Ilowite NT; Lovell DJ; Wallace CA; Rabinovich CE; Reiff A; Higgins G; Gottlieb B; Singer NG; Chon Y; Lin SL; Baumgartner SW;
Arthritis Rheum; 2009 Sep; 60(9):2794-804. PubMed ID: 19714630
[TBL] [Abstract][Full Text] [Related]
73. Assessment of the relationship between methotrexate polyglutamates in red blood cells and clinical response in patients commencing methotrexate for rheumatoid arthritis.
Pan S; Stamp LK; Duffull SB; Barclay ML; Dalrymple JM; Drake J; Zhang M; Korell J
Clin Pharmacokinet; 2014 Dec; 53(12):1161-70. PubMed ID: 25204405
[TBL] [Abstract][Full Text] [Related]
74. Prospective monitoring of Epstein-Barr virus and other herpesviruses in patients with juvenile idiopathic arthritis treated with methotrexate and tocilizumab.
Kawada J; Iwata N; Kitagawa Y; Kimura H; Ito Y
Mod Rheumatol; 2012 Aug; 22(4):565-70. PubMed ID: 22057635
[TBL] [Abstract][Full Text] [Related]
75. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
Bichler J; Benseler SM; Krumrey-Langkammerer M; Haas JP; Hügle B
Scand J Rheumatol; 2015; 44(4):280-3. PubMed ID: 25993023
[TBL] [Abstract][Full Text] [Related]
76. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
Livermore P
Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
[TBL] [Abstract][Full Text] [Related]
77. Erythrocyte-methotrexate and disease activity in children treated with oral methotrexate for juvenile chronic arthritis.
Kristensen K; Nielsen S; Karup Pedersen F; Zak M
Scand J Rheumatol; 2000; 29(3):187-9. PubMed ID: 10898073
[TBL] [Abstract][Full Text] [Related]
78. Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia.
Oosterom N; de Jonge R; Smith DEC; Pieters R; Tissing WJE; Fiocco M; van Zelst BD; van den Heuvel-Eibrink MM; Heil SG
PLoS One; 2019; 14(9):e0221591. PubMed ID: 31527879
[TBL] [Abstract][Full Text] [Related]
79. Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis.
Jansen G; van der Heijden J; Oerlemans R; Lems WF; Ifergan I; Scheper RJ; Assaraf YG; Dijkmans BA
Arthritis Rheum; 2004 Jul; 50(7):2130-9. PubMed ID: 15248210
[TBL] [Abstract][Full Text] [Related]
80. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
